Ado-trastuzumab emtansine (T-DM1) treatment results in grade 3-4 thrombocytopenia in 8%-13% of patients. Prior in vitro studies reported T-DM1 inhibition of megakaryocyte maturation as the cause of ...
A novel antiplatelet therapy showed potential in reducing blood clot risk and preventing cancer metastasis, according to preclinical research findings published in Science Translational Medicine. The ...
Tampa, Fla. (September 14th, 2009) – In two separate studies, a major component in green tea, epigallocatechin-3-O-gallate (EGCG), has been found to help prolong the preservation of both stored blood ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results